Board meeting outcome to consider and approve unaudited financial results(standalone and consolidated) for the quarter ended 30.09.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts less than Nifty Microcap 250 and 3.5 pts less than its Household Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Pee Cee Cosma Sope Ltd's board, at its meeting on November 11, 2025, approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. Standalone revenue from operations rose modestly to Rs 3,264.25 lakhs in Q2 FY26 (vs Rs 3,094.32 lakhs in Q2 FY25), with H1 FY26 revenue at Rs 7,245.23 lakhs (vs Rs 7,079.45 lakhs). However, profitability dropped sharply - Q2 standalone PAT fell to Rs 146.28 lakhs (vs Rs 266.08 lakhs) and H1 PAT fell to Rs 444.84 lakhs (vs Rs 601.41 lakhs), compressing the operating margin to about 6% in Q2 from 11.4% a year ago. Standalone operating cashflow improved to Rs 410.17 lakhs (vs negative Rs 20.76 lakhs in H1 FY25), and auditor Doogar & Associates issued an unqualified review report with no qualifications.
Weak profitability despite stable revenue and sharply lower operating margins may concern shareholders looking for earnings growth, though strong cash generation and a clean auditor's review provide some comfort. Investors should track whether margins recover in upcoming quarters.